RxDoctor Payments Data

Crystal Butler

Family · Oakwood, GANPI 1194508309

Payments from drug & device makers

$3,686in general payments, 2019–2025

Across 123 payments — averaging $29.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Novo Nordisk$356
  • Bayer$312
  • Lilly USA, LLC$219
  • Corcept Therapeutics$116
  • Otsuka America Pharmaceutical, Inc.$111
  • plus $875 from 20 others

What the payments were for

  • Travel & lodging$1,17932%
  • Food & beverage$2,50768%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,686 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$31,411
Medicare patients
185
Services billed
507

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol11$10,678
Albuterol Sulfate HfaAlbuterol Sulfate25$649
Duloxetine Hcl20$439
Atorvastatin Calcium48$403
Omeprazole16$398
Levothyroxine Sodium44$384
Rosuvastatin Calcium29$352
Fluticasone Propionate44$340
Bupropion XlBupropion Hcl16$284
Gabapentin26$275
Lisinopril34$237
Escitalopram Oxalate14$220
Amlodipine Besylate49$209
Potassium Chloride13$208
Losartan Potassium32$207

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$40$10,67811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,258 family providers in Georgia.

Other family in Oakwood

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →